Literature DB >> 16434426

Higher clearance of hepatitis C virus infection in females compared with males.

I Bakr1, C Rekacewicz, M El Hosseiny, S Ismail, M El Daly, S El-Kafrawy, G Esmat, M A Hamid, M K Mohamed, A Fontanet.   

Abstract

BACKGROUND AND AIMS: According to the literature, 14-46% of subjects clear hepatitis C virus (HCV) from blood after infection. Controversy exists about sex differences in HCV clearance rates. PATIENTS AND METHODS: We compared HCV clearance in males and females using data from a large population based study on HCV infection in Egypt. Definitions used in the paper were: cleared HCV infection (positive HCV antibody and negative HCV RNA test results) and chronic HCV infection (positive HCV antibody and positive HCV RNA test results). The study sample included 4720 village residents aged 18-65 years recruited through home based visits (n = 2425) or voluntary screening (n = 2295).
RESULTS: Overall, HCV antibody prevalence was 910/4720 (19.3% (95% confidence interval 18.2-20.4)). Of those with HCV antibodies (n = 910), 61.5% had chronic HCV infection. Compared with males, females were more likely to have cleared the virus (44.6% v 33.7%, respectively; p = 0.001). Control for age, schistosomiasis history, iatrogenic exposures, and sexual exposure to HCV did not alter the positive association between female sex and viral clearance.
CONCLUSION: This study provides strong evidence in favour of a higher HCV clearance rate in females compared with males.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434426      PMCID: PMC1856273          DOI: 10.1136/gut.2005.078147

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Sex and hepatic fibrosis.

Authors:  D M Bissell
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

2.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

3.  Changing pattern of hepatitis C virus spread in rural areas of Egypt.

Authors:  Naglaa Arafa; Mostafa El Hoseiny; Claire Rekacewicz; Iman Bakr; Sherif El-Kafrawy; Mai El Daly; Saeed Aoun; Diaa Marzouk; Mostafa K Mohamed; Arnaud Fontanet
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

4.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

Authors:  E Kenny-Walsh
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

5.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

Authors:  M Vogt; T Lang; G Frösner; C Klingler; A F Sendl; A Zeller; B Wiebecke; B Langer; H Meisner; J Hess
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

6.  Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus.

Authors:  M Abdel-Hamid; D C Edelman; W E Highsmith; N T Constantine
Journal:  J Hum Virol       Date:  1997 Nov-Dec

7.  Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.

Authors:  S Bellentani; G Pozzato; G Saccoccio; M Crovatto; L S Crocè; L Mazzoran; F Masutti; G Cristianini; C Tiribelli
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

8.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

9.  Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population.

Authors:  Barbara A Piasecki; James D Lewis; K Rajender Reddy; Scarlett L Bellamy; Steven B Porter; Robert M Weinrieb; Donald D Stieritz; Kyong-Mi Chang
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

10.  Sex differences in response to hepatitis B infection among patients receiving chronic dialysis treatment.

Authors:  W T London; J S Drew
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

View more
  43 in total

1.  Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.

Authors:  Edward L Murphy; Junyong Fang; Yongling Tu; Ritchard Cable; Christopher D Hillyer; Ronald Sacher; Darrell Triulzi; Jerome L Gottschall; Michael P Busch
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

Review 2.  Acute hepatitis C virus infection: a neglected disease?

Authors:  W L Irving
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  Hepatitis C virus clearance and gender.

Authors:  T Stroffolini; M Rapicetta; R Di Stefano
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

Review 4.  Mechanisms of HCV survival in the host.

Authors:  Ella H Sklan; Prista Charuworn; Philip S Pang; Jeffrey S Glenn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

5.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

6.  A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME).

Authors:  Leslie H Tobler; Shrein H Bahrami; Zhanna Kaidarova; Lubov Pitina; Valarie K Winkelman; Sandra K Vanderpool; Anne M Guiltinan; Stewart Cooper; Michael P Busch; Edward L Murphy
Journal:  Transfusion       Date:  2010-03-25       Impact factor: 3.157

Review 7.  Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma.

Authors:  Nico Buettner; Robert Thimme
Journal:  Semin Immunopathol       Date:  2018-11-29       Impact factor: 9.623

8.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

9.  Molecular and bioinformatic evidence of hepatitis C virus evolution in brain.

Authors:  Sarah L Fishman; Jacinta M Murray; Francis J Eng; José L Walewski; Susan Morgello; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

10.  Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.

Authors:  Abdel-Rahman N Zekri; Hanaa M Alam El-Din; Abeer A Bahnassy; Naglaa A Zayed; Waleed S Mohamed; Suzan H El-Masry; Sayed K Gouda; Gamal Esmat
Journal:  Comp Hepatol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.